Baricitinib for moderate to severe rheumatoid arthritis

  • Technology appraisal guidance
  • TA466
  • Published: 
Download guidance (PDF)

Update information

December 2020: Recommendation 1.3 updated to clarify when baricitinib can be used as monotherapy. Recommendation 1.5 added to ensure equality when using the DAS28.

ISBN: 978-1-4731-2619-0